{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T14:16:49Z","timestamp":1769523409952,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.htct.2023.07.012","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T19:52:11Z","timestamp":1693943531000},"page":"S13-S20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"S6","title":["Autologous stem cell transplantation in patients older than 65 years with multiple myeloma: a real-world study"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9179-4448","authenticated-orcid":false,"given":"Cristian Maximiliano","family":"Seehaus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1167-7186","authenticated-orcid":false,"given":"Natalia","family":"Schutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5843-9954","authenticated-orcid":false,"given":"Erika","family":"Brulc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0463-5615","authenticated-orcid":false,"given":"Gonzalo","family":"Ferini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2367-6161","authenticated-orcid":false,"given":"Jorge","family":"Arbelbide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5277-7263","authenticated-orcid":false,"given":"Dorotea","family":"Fantl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9892-5543","authenticated-orcid":false,"given":"Ana Lisa","family":"Basquiera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.htct.2023.07.012_bib0001","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.htct.2023.07.012_bib0002","first-page":"1","article-title":"Epidemiology of hematologic malignancies in real-world settings: findings from the hemato-oncology latin america observational registry study","volume":"5","author":"Tietsche de Moraes Hungria","year":"2019","journal-title":"J Glob Oncol"},{"key":"10.1016\/j.htct.2023.07.012_bib0003","doi-asserted-by":"crossref","first-page":"vii128","DOI":"10.1093\/annonc\/mdn449","article-title":"Autologous transplantation for multiple myeloma","author":"Harousseau","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.htct.2023.07.012_bib0004","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1182\/blood-2012-05-423202","article-title":"Have drug combinations supplanted stem cell transplantation in myeloma?","author":"Palumbo","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.htct.2023.07.012_bib0005","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1182\/blood-2004-02-0408","article-title":"Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial","volume":"104","author":"Palumbo","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.htct.2023.07.012_bib0006","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1182\/blood-2005-03-1301","article-title":"High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA","volume":"106","author":"Blad\u00e9","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.htct.2023.07.012_bib0007","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bbmt.2006.09.010","article-title":"High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Koreth","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.htct.2023.07.012_bib0008","article-title":"Current status of autologous stem cell transplantation for multiple myeloma","author":"Hamed","year":"2019","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.htct.2023.07.012_bib0009","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3324\/haematol.2017.174573","article-title":"From transplant to novel cellular therapies in multiple myeloma: European Myeloma Network guidelines and future perspectives","volume":"103","author":"Gay","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.htct.2023.07.012_bib0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/blood.V93.1.51","article-title":"Age is not a prognostic variable with autotransplants for multiple myeloma","author":"Siegel","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.htct.2023.07.012_bib0011","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/bmt.2014.255","article-title":"Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years","volume":"50","author":"Auner","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.htct.2023.07.012_bib0012","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0140-6736(07)61537-2","article-title":"Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99\u201306): a randomised trial","author":"Facon","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.htct.2023.07.012_bib0013","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3324\/haematol.2016.151860","article-title":"Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial","volume":"101","author":"Straka","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.htct.2023.07.012_bib0014","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1182\/blood.V128.22.3460.3460","article-title":"Favourable outcome of elderly patients with multiple myeloma treated with tandem melphalan 100 high-dose therapy, autologous stem cell transplantation and novel agents - a single center experience","volume":"128","author":"Neukirchen","year":"2016","journal-title":"Blood."},{"key":"10.1016\/j.htct.2023.07.012_bib0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejim.2018.05.027","article-title":"Special problems in the management of elderly patients with multiple myeloma","volume":"58","author":"Gay","year":"2018","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.htct.2023.07.012_bib0016","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa1714678","article-title":"Daratumumab plus bortezomib, melphalan, and prednisone for untreated myeloma","volume":"378","author":"Mateos","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.htct.2023.07.012_bib0017","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1056\/NEJMoa1817249","article-title":"Daratumumab plus lenalidomide and dexamethasone for untreated myeloma","volume":"380","author":"Facon","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.htct.2023.07.012_bib0018","unstructured":"Sociedad argentina de hematolog\u00eda. [cited 5 Mar 2023]. Available: https:\/\/www.sah.org.ar\/guias_hematolo.asp"},{"key":"10.1016\/j.htct.2023.07.012_bib0019","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","author":"Greipp","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.htct.2023.07.012_bib0020","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.bbmt.2017.06.014","article-title":"Hematopoietic cell transplantation-specific comorbidity index predicts morbidity and mortality in autologous stem cell transplantation","volume":"23","author":"Berro","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.htct.2023.07.012_bib0021","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","author":"Kumar","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.htct.2023.07.012_bib0022","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/leu.2013.313","article-title":"Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients","volume":"28","author":"Kumar","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.htct.2023.07.012_bib0023","doi-asserted-by":"crossref","first-page":"vii128","DOI":"10.1093\/annonc\/mdn449","article-title":"Autologous transplantation for multiple myeloma","author":"Harousseau","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.htct.2023.07.012_bib0024","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1002\/cncr.33171","article-title":"Age no bar: a CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma","author":"Munshi","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.htct.2023.07.012_bib0025","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1365-2141.2004.05340.x","article-title":"Less than half of patients aged 65 years or under with myeloma proceed to transplantation: results of a two region population-based survey","author":"Morris","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.htct.2023.07.012_bib0026","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3324\/haematol.2012.075051","article-title":"Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials","volume":"98","author":"Bringhen","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.htct.2023.07.012_bib0027","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3324\/haematol.2016.150334","article-title":"Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study","author":"Garderet","year":"2016","journal-title":"Haematologica"},{"issue":"13","key":"10.1016\/j.htct.2023.07.012_bib0028","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood-2014-12-615187","article-title":"Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report","volume":"125","author":"Palumbo","year":"2015","journal-title":"BloodBlood"},{"key":"10.1016\/j.htct.2023.07.012_bib0029","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1200\/JCO.2007.10.6559","article-title":"Comprehensive geriatric assessment for older patients with cancer","author":"Extermann","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.htct.2023.07.012_bib0030","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3324\/haematol.2016.162693","article-title":"A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients","volume":"102","author":"Engelhardt","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.htct.2023.07.012_bib0031","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/ajh.24532","article-title":"N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma","author":"Milani","year":"2016","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.htct.2023.07.012_bib0032","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.htct.2023.07.012_bib0033","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3324\/haematol.2017.181339","article-title":"Melphalan 140mg\/m or 200mg\/m for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT chronic malignancies working party","volume":"103","author":"Auner","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.htct.2023.07.012_bib0034","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00277-018-3528-x","article-title":"Real-life data on safety and efficacy of autologous stem cell transplantation in elderly patients with multiple myeloma","volume":"98","author":"Marini","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.htct.2023.07.012_bib0035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00277-016-2882-9","article-title":"Efficacy and safety of autologous hematopoietic cell transplantation in elderly patients with multiple myeloma: a retrospective national multi-site cohort study","author":"Cohen","year":"2017","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.htct.2023.07.012_bib0036","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1182\/blood-2013-02-483073","article-title":"Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results","volume":"122","author":"Gay","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.htct.2023.07.012_bib0037","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1200\/JCO.2009.22.7561","article-title":"Bortezomib as induction before autologous transplantation, followed by lenalidomide as consolidation-maintenance in untreated multiple myeloma patients","author":"Palumbo","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.htct.2023.07.012_bib0038","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1056\/NEJMoa1114138","article-title":"Lenalidomide maintenance after stem-cell transplantation for multiple myeloma","author":"Attal","year":"2012","journal-title":"N Engl J Med"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137923001694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137923001694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T11:06:17Z","timestamp":1737975977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137923001694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":38,"alternative-id":["S2531137923001694"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2023.07.012","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autologous stem cell transplantation in patients older than 65 years with multiple myeloma: a real-world study","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2023.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}